ACRV
Acrivon Therapeutics, Inc. Common Stock
NASDAQ: ACRV · HEALTHCARE · BIOTECHNOLOGY
$1.81
-4.74% today
Updated 2026-04-29
Market cap
$70.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.02
Dividend yield
—
52W range
$1 – $4
Volume
0.9M
Acrivon Therapeutics, Inc. Common Stock (ACRV) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-53.90%
ROA
-32.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $0.00 | $-5.31M | — | — | — |
| 2021 | $0.00 | $-16.24M | — | — | — |
| 2022 | $0.00 | $-29.68M | — | — | — |
| 2023 | $0.00 | $-60.39M | — | — | — |
| 2024 | $0.00 | $-80.56M | — | — | — |
| 2025 | $0.00 | $-77.91M | — | — | — |